If you are exploring IVF in Thailand, you may have come across terms like PGT-A and PGT-M. Both are types of preimplantation genetic testing, but they serve different purposes. This guide explains the difference, focusing on which test screens for aneuploidy, and how they may be used together.
At a Glance: PGT-A vs PGT-M
- PGT-A screens embryos for aneuploidy (abnormal number of chromosomes).
- PGT-M tests for specific genetic mutations that one or both parents carry.
- They answer different questions and can be used together in some cases.
- Neither test guarantees a pregnancy or a healthy baby.
What Is Aneuploidy?
Aneuploidy is the presence of an abnormal number of chromosomes in a cell. Humans typically have 46 chromosomes in each cell, arranged in 23 pairs. An embryo with an extra or missing chromosome is considered aneuploid. Many aneuploid embryos do not implant or result in miscarriage, and some can lead to conditions such as Down syndrome.
PGT-A is designed to detect aneuploidy in embryos created through IVF before transfer.
What Is PGT-A?
PGT-A stands for preimplantation genetic testing for aneuploidy. It screens embryos for chromosomal abnormalities, specifically looking for extra or missing chromosomes. This test can help identify embryos that are more likely to implant and develop normally, but it does not guarantee success.
PGT-A is sometimes recommended for women of advanced maternal age, couples with a history of recurrent miscarriage, or those who have had multiple failed IVF cycles. However, it is not necessary for everyone.
What Is PGT-M?
PGT-M stands for preimplantation genetic testing for monogenic disorders. It is used when one or both parents carry a specific genetic mutation that could cause a serious inherited condition, such as cystic fibrosis or Huntington’s disease. PGT-M tests embryos for that particular mutation, allowing the transfer of embryos that do not carry it.
PGT-M is not a general screening test; it is targeted to a known genetic risk.
Key Differences: PGT-A vs PGT-M
| Aspect | PGT-A | PGT-M |
|---|---|---|
| Purpose | Screens for aneuploidy (chromosomal number abnormalities) | Tests for a specific genetic mutation |
| Who may consider it | People with concerns about embryo chromosome health | Couples with a known inherited condition |
| What it detects | Extra or missing chromosomes | Presence or absence of a specific mutation |
| Can it be used together? | Yes, with PGT-M | Yes, with PGT-A |
Can PGT-A and PGT-M Be Used Together?
Yes, in some situations, both tests may be performed on the same embryo. For example, if a couple carries a genetic mutation and also wants to screen for aneuploidy, they might use PGT-M to select embryos without the mutation and PGT-A to select embryos with a normal chromosome number. This combined approach can provide more information, but it is not always necessary or available.
Discuss with your clinic whether combined testing is appropriate for your situation.
What About PGT-SR?
You may also hear about PGT-SR, which stands for preimplantation genetic testing for structural rearrangements. This test is used when one parent has a chromosomal rearrangement, such as a translocation, that could lead to unbalanced chromosomes in embryos. PGT-SR is different from PGT-A and PGT-M, but it also aims to identify embryos with a higher chance of implantation.
How Are These Tests Performed?
PGT is performed on embryos created through IVF. After fertilization, embryos are cultured for several days. A small number of cells are then biopsied from each embryo, usually on day 5 or day 6. These cells are sent to a laboratory for genetic analysis. The results help guide which embryos to consider for transfer.
The biopsy process is delicate and requires specialized expertise. The testing itself is done in a genetics laboratory, which may be located within the clinic or at an external facility.
What Do the Results Mean?
PGT-A results typically categorize embryos as:
- Euploid – normal number of chromosomes
- Aneuploid – abnormal number of chromosomes
- Mosaic – a mix of normal and abnormal cells
PGT-M results indicate whether an embryo carries the specific mutation tested for. However, results are not always black and white. Mosaic embryos, for example, may have varying levels of abnormal cells, and their potential is still being studied.
It is important to discuss your results with a genetic counselor or your doctor to understand what they mean for your specific situation.
Limitations and Considerations
PGT is a powerful tool, but it has limitations:
- It does not guarantee a pregnancy or a healthy baby.
- It cannot detect all genetic conditions or birth defects.
- It involves an invasive biopsy, which carries a small risk to the embryo.
- It is not necessary for everyone and may not be recommended for all patients.
- Results can be inconclusive or show mosaicism, which can be difficult to interpret.
Before deciding on PGT, consider your medical history, age, and personal preferences. A fertility specialist can help you weigh the potential benefits and risks.
Questions to Ask Your Clinic
If you are considering PGT in Thailand, ask your clinic:
- Which type of PGT do you recommend for my situation, and why?
- Does your laboratory have experience with PGT-A and PGT-M?
- How long will it take to get results?
- What are the costs involved, and are they separate from IVF?
- How do you handle mosaic or inconclusive results?
- Is genetic counseling available?
Next Steps
If you are exploring PGT in Thailand, take these steps:
- Research clinics that offer PGT and understand their approach.
- Schedule a consultation to discuss your medical history and testing options.
- Ask about the laboratory used for genetic analysis.
- Clarify costs and timelines.
- Consider speaking with a genetic counselor.
For more information, see our PGT in Thailand guide, explore other guides, or check our FAQ.
Frequently asked questions
Does PGT-A screen for aneuploidy?
Yes, PGT-A is specifically designed to screen embryos for aneuploidy, which is an abnormal number of chromosomes. It can identify embryos with extra or missing chromosomes, which may affect implantation or development.
Can PGT-M detect aneuploidy?
No, PGT-M is not designed to detect aneuploidy. It tests for a specific genetic mutation that one or both parents carry. If you need both aneuploidy screening and mutation testing, you may consider using PGT-A and PGT-M together.
Is PGT-A necessary for everyone doing IVF?
No, PGT-A is not necessary for everyone. It may be recommended for certain situations, such as advanced maternal age, recurrent miscarriage, or previous failed IVF cycles. Your doctor can help you decide if it is appropriate for you.
What is the difference between PGT-A and PGT-SR?
PGT-A screens for aneuploidy (chromosome number abnormalities), while PGT-SR is used when one parent has a structural rearrangement of chromosomes, such as a translocation. Both aim to identify embryos with a higher chance of implantation, but they address different types of chromosomal issues.
Continue your research
Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.